Finding |
N=51 |
Death during follow-up, n (%) |
4 (7.8) |
Cardiac-related death, n (%) |
0 (0.0) |
Lost to follow-up, n (%) |
2 (3.9) |
Rehospitalization for cardiac event, n (%) |
7 (13.7) |
Rehospitalization for non-cardiac event, n (%) |
11
(21.6) |
Aortic valve-related reintervention, n (%) |
3 (5.9) |
By indication |
|
Aortic valve insufficiency, n (%)
|
0 (0.0)
|
Aortic valve stenosis, n (%)
|
1 (2.0)
|
Endocarditis, n (%)
|
2 (3.9)
|
By type of reintervention |
|
Mechanical aortic valve replacement, n (%)
|
1 (2.0)
|
Biological aortic valve replacement, n (%)
|
0 (0.0)
|
Bentall procedure with biological prosthesis, n (%)
|
0 (0.0)
|
Bentall procedure with mechanical prosthesis, n (%)
|
2 (3.9)
|
Ross procedure, n (%)
|
0 (0.0)
|
Transcatheter aortic valve implantation, n (%)
|
0 (0.0)
|
Mortality at reintervention, n (%)
|
0 (0.0)
|
Concerning the medical treatment |
45 (88.2) |
Cardiologic medication, n (%)
|
34 (66.7)
|
Anticoagulant, n (%)
|
3 (5.8)
|
Others, n (%)
|
2 (3.9)
|
None, n (%)
|
6 (11.8)
|
Echocardiography with last 2 years |
37 (72.5) |
Left ventricular ejection fraction (%) (n=36), mean±SD
|
62.6±6.7
|
Aortic ring (mm) (n=7), mean±SD
|
22.7±4.1
|
Vmax (m/s) (n=17), mean±SD
|
2.0±0.6
|
Aortic insufficiency, n (%) |
|
0
|
31/37 (83.8)
|
1
|
5/37 (13.5)
|
2
|
1/37 (2.7)
|
3
|
0/37 (0.0)
|
4
|
0/37 (0.0)
|
Mean gradient (mmHg) (n=27), mean±SD |
9.4±5.4 |
Ascending aorta (mm) (n=22), mean±SD |
34.7±5.4 |